All Anticoagulants articles
This video has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼(rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-1924 January 2021
Independent professional body guideline
Recommendations for primary care on the role of oral anticoagulant treatment in people with non-valvular atrial fibrillation.
Working party guideline/algorithm
This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.